Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada
•Fentanyl test strips are a form of drug checking used to prevent overdose.•Distribution of fentanyl test strips for “take-home” use has not been evaluated.•Take-home testing of opioid samples provided similar results to on-site testing.•Take-home drug checking was associated with positive harm redu...
Saved in:
| Published in: | The International journal of drug policy Vol. 106; p. 103741 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Netherlands
Elsevier B.V
01-08-2022
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | •Fentanyl test strips are a form of drug checking used to prevent overdose.•Distribution of fentanyl test strips for “take-home” use has not been evaluated.•Take-home testing of opioid samples provided similar results to on-site testing.•Take-home drug checking was associated with positive harm reduction behaviours.
Drug checking is a harm reduction strategy used to identify components of illicitly obtained drugs, including adulterants, to prevent overdose. This study evaluated the distribution of take-home fentanyl test strips to people who use drugs (PWUD) in British Columbia, Canada. The primary aim was to assess if the detection of fentanyl in opioid samples was concordant between a take-home model and testing by trained drug checking staff.
Take-home fentanyl test strips were distributed at ten sites providing drug checking services from April to July 2019. The fentanyl positivity of the aggregate take-home and on-site drug checking groups were compared by class of substance tested. An administered survey assessed acceptability and behaviour change.
1680 take-home results were obtained from 218 unique participants; 68% of samples (n=1142) were identified as opioids and 23% (n=382) were stimulant samples. During this period, 852 samples were tested using on-site drug checking. The fentanyl positivity of opioid samples was 90.0% for take-home samples and 89.1% for on-site samples (Difference 0.8% (95% CI -2.3% to 3.9%)). These results were not affected by previous experience with test strips. Fentanyl positivity of stimulants in the take-home group was higher than on-site (24.7% vs. 3.2%), but the study was underpowered to conduct statistical analysis on this sub-group. When fentanyl was detected, 27% of individuals reported behaviour change that was considered safer/positive. Greater than 95% of participants stated they would use fentanyl test strips again.
Take-home fentanyl test strips used by PWUD on opioid samples can provide similar results to formal drug checking services and are a viable addition to existing overdose prevention strategies. Use of this strategy for detection of fentanyl in stimulant samples requires further evaluation. This intervention was well accepted and in some participants was associated with positive behaviour change. |
|---|---|
| ISSN: | 0955-3959 1873-4758 |
| DOI: | 10.1016/j.drugpo.2022.103741 |